Embed presentation
Download as PDF, PPTX

























































































- The Indian pharmaceutical market is worth $13 billion and expected to reach $12-13 billion by 2012, with the domestic retail market crossing $10 billion by 2010. Exports are projected to reach $22.2 billion by 2012. - Anti-infectives are the largest therapeutic category, accounting for 19% of the domestic market. Acute therapy currently dominates sales but the chronic segment is expected to fuel future growth. - Exports are a major growth driver and are projected to surpass the domestic market by 2010. Generics will be a key growth area, with Indian firms' US market share forecast to exceed 6% by 2011-2012. India also maintains a focus on bulk drug























































































